Meghmani Finechem Analyst Rating
based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 1 analysts offering long term price targets for Meghmani Finechem. An average target of ₹2000
Source: S&P Global Market Intelligence
Meghmani Finechem Share analysis
Meghmani Finechem price forecast by 1 analysts
Upside of15.43%
High
₹2000
Target
₹2000.00
Low
₹2000
Meghmani Finechem target price ₹2000, a slight upside of 15.43% compared to current price of ₹1732.7. According to 1 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Meghmani Finechem revenue growth forecast
Expected growth rate Q1, FY2027:57.81%
Forecast
Actual
Including amortisation and stock based compensations
Meghmani Finechem EPS growth forecast
EPS estimate Q1, FY2027:28.90%
Forecast
Actual
Source: S&P Global Market Intelligence
Meghmani Finechem Performance
Day's Low
Day's High
₹1,702.2Day's Price Range₹1,751.9552 Week's Low
52 Week's High
₹931.652-Week Price Range₹2,406.75
| Returns % | |
| 1 Month Return | -11.87 % |
| 3 Month Return | -18.39 % |
| 1 Year Return | + 70.79 % |
| Market Stats | |
| Previous Close | ₹1,738.55 |
| Open | ₹1,723.70 |
| Volume | 36.72K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹7,475.10Cr |
Meghmani Finechem Key Statistics
| P/E Ratio | 24.53 |
| PEG Ratio | 1.45 |
| Market Cap | ₹7,475.10 Cr |
| P/B Ratio | 3.63 |
| EPS | 47.14 |
| Dividend Yield | 0.46 |
| Sector | Chemicals |
| ROE | 16.85 |
Meghmani Finechem Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹7,475.10 Cr | 65.26% | 0.71 | ₹195 Cr | ₹1,929 Cr | |
| NA | ₹18.58 Cr | 18.02% | 2.12 | NA | NA | |
| BUY | ₹3,137.45 Cr | 19.08% | 0.55 | ₹123 Cr | ₹1,949 Cr | |
| NA | ₹192.79 Cr | -11.37% | 0.67 | ₹12 Cr | ₹714 Cr | |
| NA | ₹1,214.53 Cr | 5.52% | 0.54 | ₹76 Cr | ₹1,894 Cr |
About Meghmani Finechem
Share Price: ₹1732.70 per share as on 17 Jan, 2025 04:01 PM
Market Capitalisation: ₹7,475.10Cr as of today
Revenue: ₹626.06Cr as on September 2024 (Q3 24)
Net Profit: ₹81.30Cr as on September 2024 (Q3 24)
Listing date: 18 Aug, 2021
Chairperson Name: Maulik Jayantibhai Patel
| Organisation | Meghmani Finechem |
| Headquarters | Ahmedabad |
| Industry | Chemicals |
| E-voting on shares | Click here to vote |
Key events for Epigral Ltd
Epigral Stock Downgraded Amid Valuation Concerns - 06 Jan, 2025
Epigral received a 'Sell' downgrade due to high valuation metrics despite a 36.89% increase in net sales. The stock shows a sideways trend with a slight decline of 4.61% since the downgrade.
Insights on Epigral Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, EPIGRAL has outperformed top 5 stocks with highest market-cap in Commodity Chemicals
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 1.04% to 3.68% in Oct 2024 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 2.09% to 3.02% in Oct 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Solar Industries India Ltd has given 297.3% return, outperforming this stock by 195.1%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 85.87 Cr → 81.3 Cr (in ₹), with an average decrease of 5.3% per quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 71.58% to 68.94% in Oct 2024 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 25.13% to 24.20% in Oct 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 653.6 Cr → 632.38 Cr (in ₹), with an average decrease of 3.3% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, EPIGRAL stock has moved down by -15.3%
Meghmani Finechem Financials
Index Inclusions
Meghmani Finechem Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 68.94% | ||
| Foreign Institutions | 3.02% | 44.38 | |
| Mutual Funds | 3.68% | 254.99 | |
| Retail Investors | 24.2% | ||
| Others | 0.15% |
Meghmani Finechem Key Indicators
Meghmani Finechem Valuation
Meghmani Finechem in the last 5 years
Lowest (9.04x)
March 28, 2023
Today (24.53x)
January 17, 2025
Industry (55.45x)
January 17, 2025
Highest (38.05x)
September 24, 2024
Meghmani Finechem Earnings and Dividends
Epigral Ltd Earnings Results
Epigral Ltd’s net profit jumped 114% since last year same period to ₹81.30Cr in the Q2 2024-2025. On a quarterly growth basis, Epigral Ltd has generated -5.32% fall in its net profits since last 3-months.
Read More about Earnings ResultsEpigral Ltd Dividends April,2024
In the quarter ending March 2024, Epigral Ltd has declared dividend of ₹5 - translating a dividend yield of 0.43%.
Read More about Dividends
Meghmani Finechem Technicals Summary
Bearish
Neutral
Bullish
Epigral Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Epigral Ltd
Epigral Ltd share price today stands at ₹1732.7, Open. ₹1723.7 ; Previous Close. ₹1738.55 ; High. ₹1751.95 ; Low. ₹1702.2 ; 52 Week High. ₹2406.75 ; 52 Week Low: ₹931.6.
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Epigral Ltd shares.
Epigral Ltd is listed on NSE
Epigral Ltd is listed on BSE
- Today’s highest price of Epigral Ltd is ₹1751.95.
- Today’s lowest price of Epigral Ltd is ₹1702.2.
PE Ratio of Epigral Ltd is 24.53
PE ratio = Epigral Ltd Market price per share / Epigral Ltd Earnings per share
Today’s traded volume of Epigral Ltd(EPIGRAL) is 36.72K.
Today’s market capitalisation of Epigral Ltd(EPIGRAL) is ₹7475.1Cr.
| Epigral Ltd(EPIGRAL | Price |
|---|---|
52 Week High | ₹2406.75 |
52 Week Low | ₹931.6 |
Epigral Ltd(EPIGRAL) share price is ₹1732.7. It is down -28.01% from its 52 Week High price of ₹2406.75
Epigral Ltd(EPIGRAL) share price is ₹1732.7. It is up 85.99% from its 52 Week Low price of ₹931.6
| Epigral Ltd(EPIGRAL | Returns |
|---|---|
1 Day Returns | -5.85% |
1 Month Returns | -11.87% |
3 Month Returns | -18.39% |
1 Year Returns | 70.79% |